OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
March 29, 2016
Industry is joining with academia and global health leaders to examine new approaches to biotech manufacturing.
Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.
A team of Bristol-Myers Squibb scientists will work in a new laboratory at the National Institute of Bioprocessing Research and Training facility in Dublin, Ireland.
March 24, 2016
Collaboration will provide for unified development and manufacture of antibody drug conjugates.
March 22, 2016
The Human Vaccines Project brings together academic research centers, industrial partners, nonprofit organizations, and governments to address the primary scientific barriers to developing new vaccines and immunotherapies.
March 18, 2016
During a clinical trial of 48 participants, 100% of those that received the TV003 vaccine were protected from infection.
March 15, 2016
The author discusses key areas of focus and presents best practices from the International Pharmaceutical Excipients Council (IPEC).
March 14, 2016
Wear-resistant materials and coatings protect tablet punches and dies from abrasive formulations.
March 10, 2016
The syriQ Rigid Cap (SRC) and SCHOTT TopPac Rigid Cap (TRC) closure systems from Schott use an intuitive twist-off mechanism for ease of use and container closure integrity.
Hovione will operate a commercial-scale continuous manufacturing facility in New Jersey as part of an agreement with Vertex Pharmaceuticals.